menu013.png

Scientific advisory board

Manel Esteller

Manel Esteller is graduated in Medicine with Honours from the Universitat de Barcelona in 1992, where he also obtained his PhD degree in molecular genetics in 1996. He was an Invited Researcher at the School of Biological and Medical Sciences at the University of St. Andrews (Scotland, UK). From 1997 to 2001, Dr. Esteller was a researcher at the Johns Hopkins University and School of Medicine (Baltimore, USA) where he was decisive in establishing promoter hypermethylation of tumour suppressor genes as a common hallmark of all human tumours. From October 2001 to September 2008 Manel Esteller was the leader of the CNIO Cancer Epigenetics Laboratory. Currently, Dr Manel Esteller is Director of the Cancer Epigenetics and Biology Program (PEBC) of the Bellvitge Institute for Biomedical Research (IDIBELL).

 

Manel Esteller

 

Fernando Cossío

Fernando Cossío is professor of Organic Chemistry at the University of the Basque Country. He held several post-doctoral positions at the University of California, Los Angeles (UCLA) and Centre Nationale de la Recherche Scientifique (CNRS) in Bourdeaux. He has more than 180 publications and patents in organic, medicinal and theoretical chemistry. His group was selected in 2007 as one of the most productive groups at the chemistry faculty of the University of the Basque Country. His wide knowledge in organic chemistry and computer aided drug design with a highly valuable background in the process of drug design and novel synthetic methods.

 

Fernando Cossio
 

   QUIMATRYX

   Paseo Mikeletegi 69, 3ª planta

   20009 San Sebastián

   Tel: 946 08 70 37

   www.quimatryx.com